Please inform us as early as possible to give us some leeway, because the amount of time necessary for a negotiation will vary depending on each case. In cases where an adjustment of its relationship with other agreements or confirmation with a third party is needed, it may be necessary to negotiate for a fairly long time. Clerical formalities (such as obtaining internal approvals or affixing seals) after the details of the agreement are set usually take a month or so.
It depends on each case, so please consult with us. For example, in cases where the purpose of the collaborative research is the screening of a compound, in addition to the handling of patents or the like, a careful review is necessary to determine whether cell strains or experimental animals provided as screening tools can be provided for free or not.
Since the amount of the consideration is one of the contractual terms, and there should be a balance with other terms and conditions, it is decided by the Office of Society-Academia Collaboration for Innovation based on the researcher’s intention.
Since the funds used in the creation are public funds, a rough estimate would be a level not lower than the actual amount of expenses. However, considering that provision of tangible research material is only a utilization of the research results, which is different from sales of test reagents or the like, the consideration will not be necessarily at the same level as the market price, but it will be decided by taking into account elements such as the difficulty of creation and research value.
The income accruing from an MTA for consideration will be split eighty percent (80%) to the departments/divisions and twenty percent (20%) to the administrative office of the University (Article 10.1 of the Kyoto University Regulations on Handling Tangible Research Results). The allocation within the departments/divisions will be made according to the determination of each department/division, and the person in charge in the respective departments/divisions should be asked whether there should be an allocation to a laboratory or not.
In cases where a tangible research material obtained from a third party is used, let us know the background of the acquisition of such a third party material, the written contract, e-mail records or the like, if any, to the extent it is permissible. Even if it is a test reagent or the like that is being offered commercially, there may be cases where restrictions provided forth in the package or catalog thereof.